Concentric Capital Strategies, LP Abbott Laboratories Transaction History
Concentric Capital Strategies, LP
- $1.94 Billion
- Q2 2024
A detailed history of Concentric Capital Strategies, LP transactions in Abbott Laboratories stock. As of the latest transaction made, Concentric Capital Strategies, LP holds 3,042 shares of ABT stock, worth $360,781. This represents 0.02% of its overall portfolio holdings.
Number of Shares
3,042Holding current value
$360,781% of portfolio
0.02%Shares
3 transactions
Others Institutions Holding ABT
# of Institutions
3,167Shares Held
1.33BCall Options Held
8.63MPut Options Held
7.19M-
Vanguard Group Inc Valley Forge, PA166MShares$19.7 Billion0.34% of portfolio
-
Black Rock Inc. New York, NY131MShares$15.6 Billion0.31% of portfolio
-
State Street Corp Boston, MA74.4MShares$8.82 Billion0.34% of portfolio
-
Capital International Investors Los Angeles, CA71.8MShares$8.52 Billion1.57% of portfolio
-
Capital Research Global Investors Los Angeles, CA57.2MShares$6.79 Billion1.34% of portfolio
About ABBOTT LABORATORIES
- Ticker ABT
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 1,751,219,968
- Market Cap $208B
- Description
- Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...